Agranulocytosis Following Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma.
Saved in:
| Title: | Agranulocytosis Following Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma. |
|---|---|
| Authors: | Uchida G; Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan., Hiraga J; Department of Hematology, Toyota Kosei Hospital, Japan., Morita K; Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan., Takeuchi A; Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan., Takashi H; Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan., Furune S; Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan., Tsuzuki T; Department of Gastroenterology and Hepatology, Toyota Kosei Hospital, Japan. |
| Source: | Internal medicine (Tokyo, Japan) [Intern Med] 2026 Apr 01; Vol. 65 (7), pp. 1043-1048. Date of Electronic Publication: 2025 Sep 11. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1349-7235 |
|---|---|
| DOI: | 10.2169/internalmedicine.5910-25 |
